Stock GMRE GLOBAL MEDICAL REIT INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Global Medical REIT Inc.

Equities

GMRE

US37954A2042

Specialized REITs

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
8.11 USD +0.25% Intraday chart for Global Medical REIT Inc. -0.98% -26.94%
Mar. 07 Global Medical REIT Keeps Quarterly Dividend at $0.21 Per Share, Payable April 9 to Shareholders on March 22 MT
Mar. 07 Global Medical REIT Inc. Declares Cash Dividend for the First Quarter 2024, Payable on April 9, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 567.2 629.3 1,140 621.1 727.8 531.9 - -
Enterprise Value (EV) 1 567.2 1,210 1,704 621.1 727.8 1,169 1,166 531.9
P/E ratio 132 x -76.8 x 93.4 x 47.4 x 48.3 x 360 x 143 x 203 x
Yield 6.05% 6.13% 4.62% 8.86% - 10.4% 10.6% 11%
Capitalization / Revenue 8.02 x 6.71 x 9.83 x 4.52 x 5.16 x 3.85 x 3.69 x 3.63 x
EV / Revenue 8.02 x 12.9 x 14.7 x 4.52 x 5.16 x 8.47 x 8.08 x 3.63 x
EV / EBITDA 11 x 23 x 20.3 x 6.52 x 7.64 x 12.3 x 11.4 x 4.59 x
EV / FCF - -6,608,668 x - - - - - -
FCF Yield - -0% - - - - - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 42,872 48,188 64,208 65,518 65,565 65,587 - -
Reference price 2 13.23 13.06 17.75 9.480 11.10 8.110 8.110 8.110
Announcement Date 3/4/20 3/3/21 2/28/22 2/28/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 70.73 93.73 115.9 137.3 141 138.1 144.3 146.4
EBITDA 1 51.7 52.53 84 95.2 95.2 94.88 102.3 115.9
EBIT 1 27.06 16.18 37.12 38.47 37.07 35.23 - -
Operating Margin 38.26% 17.26% 32.02% 28.02% 26.28% 25.52% - -
Earnings before Tax (EBT) 9.588 -2.499 - - - - - -
Net income 1 3.412 -7.747 11.8 13.32 14.79 0.9565 3.233 2.201
Net margin 4.82% -8.27% 10.18% 9.7% 10.49% 0.69% 2.24% 1.5%
EPS 2 0.1000 -0.1700 0.1900 0.2000 0.2300 0.0225 0.0567 0.0400
Free Cash Flow - -183.2 - - - - - -
FCF margin - -195.41% - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 0.8000 0.8000 0.8200 0.8400 - 0.8400 0.8600 0.8933
Announcement Date 3/4/20 3/3/21 2/28/22 2/28/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 29.98 30.34 31.88 33.7 35.41 36.31 36.23 36.35 35.51 32.96 34.68 34.56 34.55 34.99 35.9
EBITDA 1 23.4 21.88 22.27 23.27 24.65 25 24.85 24.66 23.91 21.78 23.63 23.85 23.92 24.54 24.84
EBIT 1 10.2 9.232 9.087 9.235 10.24 9.912 9.959 9.859 9.714 7.535 9.356 8.928 8.6 8.349 -
Operating Margin 34.01% 30.42% 28.51% 27.41% 28.92% 27.3% 27.49% 27.12% 27.36% 22.86% 26.97% 25.83% 24.89% 23.86% -
Earnings before Tax (EBT) 5.368 - 4.286 3.834 10.03 - - - - - - - - - -
Net income 1 3.689 3.804 2.661 2.236 8.057 0.369 0.673 11.82 3.138 -0.84 0.1692 0.1195 0.2193 0.4485 0.3102
Net margin 12.3% 12.54% 8.35% 6.64% 22.76% 1.02% 1.86% 32.52% 8.84% -2.55% 0.49% 0.35% 0.63% 1.28% 0.86%
EPS 2 0.0600 0.0600 0.0400 0.0300 0.1200 0.0100 0.0100 0.1800 0.0500 -0.0100 0.005000 0.002500 0.005000 0.007500 0.0100
Dividend per Share 2 0.2050 0.2050 0.2100 0.2100 0.2100 0.2100 0.2100 0.2100 0.2100 - 0.2100 0.2100 0.2100 0.2100 0.2167
Announcement Date 11/3/21 2/28/22 5/4/22 8/3/22 11/2/22 2/28/23 5/3/23 8/2/23 11/6/23 2/27/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 581 565 - - 637 634 -
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) - 11.06 x 6.721 x - - 6.714 x 6.199 x -
Free Cash Flow - -183 - - - - - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 3/4/20 3/3/21 2/28/22 2/28/23 2/27/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Global Medical REIT Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
8.11 USD
Average target price
10.79 USD
Spread / Average Target
+33.07%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Healthcare REITs

1st Jan change Capi.
GLOBAL MEDICAL REIT INC. Stock Global Medical REIT Inc.
-26.94% 532M
WELLTOWER INC. Stock Welltower Inc.
+4.62% 55.76B
VENTAS, INC. Stock Ventas, Inc.
-11.72% 17.72B
HEALTHPEAK PROPERTIES, INC. Stock Healthpeak Properties, Inc.
-5.05% 13.23B
OMEGA HEALTHCARE INVESTORS, INC. Stock Omega Healthcare Investors, Inc.
+1.40% 7.68B
HEALTHCARE REALTY TRUST INCORPORATED Stock Healthcare Realty Trust Incorporated
-16.54% 5.39B
CARETRUST REIT, INC. Stock CareTrust REIT, Inc.
+8.62% 3.28B
AEDIFICA SA Stock Aedifica SA
-5.42% 3.06B
MEDICAL PROPERTIES TRUST, INC. Stock Medical Properties Trust, Inc.
-8.15% 2.73B
NATIONAL HEALTH INVESTORS, INC. Stock National Health Investors, Inc.
+12.61% 2.73B
Healthcare REITs
  1. Stock Market
  2. Equities
  3. GMRE Stock
  4. Financials Global Medical REIT Inc.